High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.

Fiche publication

Date publication

avril 2020

Journal

Cellular oncology (Dordrecht)

Auteurs

Membres identifiés du Cancéropôle Est :
Mme HENRIQUES Julie

Tous les auteurs :
Zaanan A, Calmel C, Henriques J, Svrcek M, Blons H, Desbois-Mouthon C, Merabtene F, Goumard C, Parc Y, Gayet B, Taieb J, Validire P, Louvet C, Fléjou JF, Le Bouc Y, Praz F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31823290

Résumé

The aim of this study was to investigate the association between expression of insulin-like growth factor-1 receptor (IGF1R) and its ligand, IGF-II, and disease-free survival (DFS) in patients with stage III colon cancer (CC).